Personal tools
You are here: Home → Knowledge Base → Psychiatric Drug Industry → US Congress Investigates Psychiatric Drug Industry
Look inside...
 

US Congress Investigates Psychiatric Drug Industry

Several different USA Congressional committees have been asked to investigate corruption, fraud and cover-up by the psychiatric drug industry.

Article Top Psychiatrist Didn't Report Drug Makers' Pay
NY Times continues coverage of congressional investigation led by Senator Charles E. Grassley (R-IA) exposing psychiatric drug company corruption, this time involving Dr. Charles B. Nemeroff of Emory University, who has resigned as chair of his department.
Article "Psychiatric Group Faces Scrutiny Over Industry Ties"
In this article, The New York Times covers the demand by Senator Charles E. Grassley (R-IA) that the APA become more transparent in its financing after numerous conflicts of interest were revealed.
Folder Sunday New York Times on Congressional investigation of Harvard psychiatrist
US Senator Charles E. Grassley helped investigate corruption by the psychiatric drug industry. His investigation revealed that Harvard psychiatrist Dr. Joseph Biederman had illegally covered up much of more than a million dollars he had received from the psychiatric drug industry. Dr. Biederman is credited with helping to increase the number of young people diagnosed as "bipolar" many-fold.
Article House Lawmaker Seeks Data From Makers of Stents and Drugs
Congressman Henry Waxman (D-Calif.) is looking into allegations of inappropriate marketing of Zyprexa and other drugs and medical devices, according to Reuters. Waxman is the chairman of a house committee investigating off-label drug marketing by Eli Lilly & Company, AstraZeneca and Cephalon. Off-label use occurs when doctors prescribe products for unapproved purposes.
Article Research Center Tied to Drug Company
Further reports from The New York Times about how a Congressional investigation revealed that psychiatrist Dr. Joseph Biederman misused the name of his institution -- Harvard -- to fraudulently promote the massive use of the psychiatric drgus known as neuroleptics or antipsychotics.
Article Expert or Shill?
The New York Times editorial board weighs in on the corruption in the psychiatric industry exposed by recent USA Congressional investigations.
Article No Mugs, but What About Those Fees
The Sunday New York Times editorialized that the corruption exposed between the psychiatric profession and the drug industry must end.
Document Actions

We are MFI



Samantha Johnson, psychiatric survivor, MFI intern

Samantha Johnson is a 22-year-old psychiatric survivor who is interning at the MindFreedom International office. "I was absolutely in disbelief at how the people were treated at the hospital. It was an environment of emotional abuse interspersed with 'treatments' and 'policies' that could be more accurately described as assault. The tragic thing is that there really are some good people working there, but they are unable to provide people with the help they need inside a system that prioritizes profits over people. It might take five years of counseling for someone to truly recover from a mental health crisis, but it takes five minutes to tranquilize them. This is why I started working with MindFreedom. For 25 years MFI has been challenging the mental health system to see us as human beings- to treat us as human beings- through peaceful activism. At MFI we emphasize individual choice, empowerment, and compassion as necessary aspects of a true healing process."

E-alerts

Facebook Like Box